Following were the findings on different parameters of this study.
Liver function test (LFT)
Serological assay was conducted on weekly interval from day 0-42 (6 weeks). Statistical analysis revealed a significant increase (P<0.05) in total bilirubin (0.145 mg/dL±0.042), (ALT U/L 60.6±10.99), AST (48.8 U/L±8.9) and ALP (107.55 U/L±15.5). The value of bilirubin was mildly raised in Treatment group, in contrary to control group (Fig 6, Table 1).
According to the findings of present study, Medroxyprogesterone Acetate has the tendency to affect liver enzymes as elevations 1 to 2 weeks following the treatment were observed. Mainly there was AST, ALT elevation without changes in ALP or bilirubin. These abnormalities had short durations and returned to normal till the end of study. Severe Hepatitis, in another study, has been documented due to the use of synthetic hormones (
Ruggieri, 2018). Same findings were reported by
Ojokuku (2010) who stated increased liver profile values during the study.
In another study, in contrary to present study, liver adenoma leading to bilirubinemia due to synthetic progesterone has been documented (
Mehmood, 2018).
Lipid profile
Statistical raise (P<0.05) in total serum cholesterol (71.7 mg/dL±14.47), HDL (64.291 mg/dL±6.42), LDL (77.38 mg/dL±9.45), TGs (377 mg/dL±75.68) was observed on serological assay conducted on weekly interval.
The value of LDL and cholesterol were raised in Treatment group after the Administration of Medroxyprogesterone Acetate on day 7 while no change observed in control group. Similar trend was observed on day 14 and 21.
Pronounced increases were seen in serological parameters after Medroxyprogesterone Acetate administration in Treatment group whereas drop in LDL, Triglyceride value were observed in control group. On day 35 more increase in lipid profile was observed in Treatment group as compared to control group (Fig 6, Table 1).
In present study laboratory investigations documented the raised lipid profile values after the use of synthetic progesterone in the treatment group, similar results have been documented by
Dai (2004). The same findings have also been reported earlier by
Tikkanen (1996) that also states that the use of synthetic progesterone has an association with chronic heart disease (CHD).
Blood glucose
Statistical analysis revealed a significant increase (P<0.05) in blood glucose level (135.71 mg/dL±18.67) as compared to control group (109.11 mg/dL±11.71), although the levels were in normal ranges (Fig 6, Table 1).
Increased glucose levels in blood were documented in the present study which is in-line with the study of
Adams (1990) which may also lead to diabetes mellitus (
Xiang, 2006). Progesterone stimulates deposition of body fat as well which leads to obesity (
Plagemann, 2006) which is commonly encountered clinically evident side effect of progestins in humans and other small animals.
Sonographic evaluation of uterus
No abnormality was seen in female rabbits during ultrasound examination. Ultrasonographic examination was performed in both groups on 7 days intervals from days 0-42 to evaluate in vivo uterine morphology. Ultrasonography did not reveal any significantly identifiable uterine or associated abnormality even in one female rabbit in which dead macerated fetuses were recovered on necropsy. Because the size of uterus is very small and placed in the deep of pelvic cavity so uterus not observe in ultrasound (
Hodges, 2013).
Histopathological findings
Histopathological findings revealed congestion, engorgement of blood vessels, degeneration, hyperplasia of epithelium of uterine wall and uterine glands in Treatment group while mild proliferation of fibrous connective tissue, infiltration of inflammatory cells, mild congestion and degeneration in control group were recorded (Fig 2-5).
Necropsy examination revealed increased uterine thickness and uterine size in Treatment group but no abnormality was observed in control group, the same findings were documented by
Walter (2005). Congestion, engorgement of blood vessels, degeneration, hyperplasia of epithelium of uterine wall and uterine glands in Treatment group was also evident as stated in the previously published data by
De Bosschere (2003) while mild proliferation of fibrous connective tissue, infiltration of inflammatory cells, mild congestion and degeneration in control group were also observed similar to report of
Aydin (2009).